LFCR Stock Summary and Trading Ideas (Lifecore Biomedical | NASDAQ:LFCR)

Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.

Lifecore Biomedical trades on the NASDAQ stock market under the symbol LFCR.

As of April 2, 2026, LFCR stock price was flat at $3.84 with 594,070 million shares trading.

LFCR has a beta of 2.17, meaning it tends to be more sensitive to market movements. LFCR has a correlation of 0.27 to the broad based SPY ETF.

LFCR has a market cap of $143.87 million. This is considered a Micro Cap stock.

In the last 3 years, LFCR traded as high as $11.46 and as low as $3.40.

The top ETF exchange traded funds that LFCR belongs to (by Net Assets): VTI, VXF, IWM, VTWO, IWO.

LFCR has underperformed the market in the last year with a price return of -45.4% while the SPY ETF gained +18.2%. LFCR has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -53.1% and -7.5%, respectively, while the SPY returned -3.6% and -0.6%, respectively.

LFCR support price is $3.68 and resistance is $4.00 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LFCR shares will trade within this expected range on the day.